I have some inside knowledge from friend who worked for Theranos. They actually did have some technology that possibly, maybe given enough time and money, could work for rapid testing of certain analytes from a capillary (fingerstick) sample. Nothing close to the 200+ analyte claims she was making, but possibly an infectious disease panel including HIV, Hep, Chlamydia, etc.
Theranos packaged up their technology, warts and all, and tried to unload it to a few big players like Samsung when the tires started to come off. None of the big players wanted to touch it, not because it did not have potential, but because of the baggage associated with it.
Trieatalot
It's a C minus world.
Theranos packaged up their technology, warts and all, and tried to unload it to a few big players like Samsung when the tires started to come off. None of the big players wanted to touch it, not because it did not have potential, but because of the baggage associated with it.
Trieatalot
It's a C minus world.